Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: Results of an international, randomized, open-label study

Clinical Infectious Diseases

Volumn 38, Issue 12, 2004, Pages 1716-1723

  Camus, Daniel ^a   Djossou, Félix ^b   Schilthuis, Herbert J ^c,d   Høgh, Birthe ^e   Dutoit, Emmanuel ^a   Malvy, Denis ^b   Roskell, Neil S ^f   Hedgley, Corinne ^f,h   De Boever, Erika H ^g   Miller, Gerri B ^g   Brook, Pat ⁱ  

^a INSTITUT PASTEUR DE LILLE   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

^d Inspectorate of Health Care   (Netherlands)

^e International Travel Vaccination Centre   (Denmark)

^f GLAXOSMITHKLINE   (United Kingdom)

^g GLAXOSMITHKLINE   (United States)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; PROGUANIL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DIZZINESS; DREAMING; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LETHARGY; MALARIA; MALE; MOUTH ULCER; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRAVEL; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VOMITING;

ADOLESCENT; ANTIMALARIALS; ATOVAQUONE; CHILD; CHILD, PRESCHOOL; CHLOROGUANIDE; CHLOROQUINE; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA; NAPHTHOQUINONES; PATIENT COMPLIANCE; TRAVEL;

EID: 2942637327     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421086     Document Type: Article

References (26)

1. Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis 2001; 33:226-34.
2. Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-95): trends and perspectives. Bull World Health Organ 1999; 77:506-6.
3. Holtz TH, Kacher SP, MacArthur JR, et al. Malaria surveillance - United States, 1998. MMWR Surveill Summ 2001; 50:1-20.
4. Lobel HO, Baker MA, Gras FA, et al. Use of malaria prevention measures by North American and European travelers for East Africa. J Travel Med 2001; 8:167-72.
5. Robinson P, Jenney AW, Tachado M, et al. Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. J Travel Med 2001; 8:76-81.
6. Dorsey G, Gandhi M, Oyugi JH, Rosenthal PJ. Difficulties in the prevention, diagnosis, and treatment of imported malaria. Arch Intern Med 2000; 160:2505-10.
7. Centers for Disease Control and Prevention. Malaria deaths following inappropriate malaria chemoprophylaxis - US, 2001. MMWR Morb Mortal Wkly Rep 2001; 50:597-9.
8. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Am J Trop Med Hyg 1999; 60: 533-41.
9. Shanks GD, Kremsner PG, Sukwa TY, et al. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med 1999; 6(Suppl 1):S21-7.
10. Sukwa TY, Mulenga M, Chisaka N, Roskell NS, Scott TR. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone-proguanil) for the prophylaxis of malaria in Zambia. Am J Trop Med Hyg 1999; 60:521-5.
11. Shanks GD, Gordon DM, Klotz FW, et al. Efficacy and safety of atovaquone-proguanil for suppressive prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis 1998; 27:494-9.
12. Lell B, Luckner D, Ndjave M, Scott T, Kremsner PG. Randomized placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 1998; 351:709-13.
13. Overbosch D, Schilthuis H, Bienzle U, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: results from a randomized, double-blind study. The Malarone International Study Team. Clin Infect Dis 2001; 33:1015-21.
14. Høgh B, Clarke PD, Camus D, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travelers: a randomized, double-blind study. The Malarone International Study Team. Lancet 2000; 356:1888-94.
15. Stauffer WM, Konop RJ, Kamat D. Traveling with infants and young children. Part I: anticipatory guidance: travel preparation and preventive health advice [review]. J Travel Med 2001; 8:254-9.
16. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med 2000; 342:1716-25.
17. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers. BMJ 1996; 313:525-8.
18. Carme B, Peguet C, Neves G. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travelers to sub-Saharan Africa. Trop Med Int Health 1997; 2:953-6.
19. Malaria. Lægemiddel Kataloget Online. 2004 (updated). Available at: http://www.lk-online.dk. Accessed 1999.
20. Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the United Kingdom. PHLS Malaria Reference Laboratory, London School of Hygiene and Tropical Medicine. Comm Dis Rep CDR Rev 1997; 7:R137-52.
21. Webster HK, Boudreau EF, Pang LW, Permpanich B, Sookto P, Wirtz RA. Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32). J Clin Microbiol 1987; 25:1002-8.
22. Bwire R, Slootman EJ, Verhave JP, Bruins J, van Leeuwen WM. Malaria anticircumsporozoite antibodies in Dutch soldiers returning from sub-Saharan Africa. Trop Med Int Health 1998; 3:66-9.
23. Nothdurft HD, Jelinek T, Bluml A, von Sonnenburg F, Loscher T. Seroconversion to circumsporozoite antigen of Plasmodium falciparum demonstrates a high risk of malarial transmission in travelers to east Africa. Clin Infect Dis 1999; 28:641-2.
24. Ling J, Baird JK, Fryauff DJ, et al. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. The Naval Medical Research Unit 2 Clinical Trial Team. Clin Infect Dis 2002; 35:825-33.
25. Faucher JF, Binder R, Missinou MA, et al. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis 2002; 35:1147-54.
26. Causer L, Newman RD, Barber AM, et al. Malaria surveillance - United States, 2000. MMWR Surveill Summ 2002; 51(SS-05):9-21.